|
Delayed
Australian S.E.
04:41:36 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 195.86 AUD | -0.23% |
|
+6.12% | +13.46% |
| 10-20 | BHP and National Australia Bank drag Aussie shares lower | RE |
| 10-14 | EU Accepts Sanofi's Concessions to End Antitrust Probe Over Vaccine Marketing -- Update | DJ |
Company Valuation: CSL Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 89,299 | 89,052 | 95,184 | 76,024 | 38,015 | 65,815 | - | - |
| Change | - | -0.28% | 6.89% | -20.13% | -50% | 73.13% | - | - |
| Enterprise Value (EV) 1 | 88,520 | 99,731 | 105,710 | 85,005 | 47,398 | 75,082 | 74,785 | 74,273 |
| Change | - | 12.66% | 5.99% | -19.59% | -44.24% | 58.41% | -0.4% | -0.68% |
| P/E | 38.6x | 40.8x | 36.1x | 25.4x | -14.8x | 22.7x | 20.6x | 19.5x |
| PBR | 6.13x | 5.64x | 5.48x | 3.93x | 2.57x | 4.05x | 3.71x | 3.38x |
| PEG | - | -7.25x | 1.8x | 1.9x | 0x | -0x | 2x | 3.64x |
| Capitalization / Revenue | 8.45x | 6.69x | 6.43x | 4.89x | 2.41x | 4.18x | 4.03x | 3.87x |
| EV / Revenue | 8.38x | 7.49x | 7.14x | 5.46x | 3x | 4.77x | 4.58x | 4.37x |
| EV / EBITDA | 24.6x | 25.6x | 22.3x | 16.5x | 10.7x | 14.8x | 14.1x | 13.3x |
| EV / EBIT | 30.2x | 32.5x | 27.7x | 19x | 10.3x | 17.2x | 16.3x | 15.4x |
| EV / FCF | 57.1x | 72.6x | 55.2x | 29.1x | 16.5x | 23.9x | 25.5x | 24.1x |
| FCF Yield | 1.75% | 1.38% | 1.81% | 3.44% | 6.05% | 4.19% | 3.93% | 4.15% |
| Dividend per Share 2 | 2.22 | 2.36 | 2.64 | 2.92 | 2.92 | 2.996 | 3.178 | 3.411 |
| Rate of return | 1.2% | 1.28% | 1.34% | 1.86% | 3.68% | 2.18% | 2.31% | 2.48% |
| EPS 2 | 4.8 | 4.53 | 5.45 | 6.17 | -5.35 | 6.063 | 6.68 | 7.038 |
| Distribution rate | 46.3% | 52.1% | 48.4% | 47.3% | -54.6% | 49.4% | 47.6% | 48.5% |
| Net sales 1 | 10,562 | 13,310 | 14,800 | 15,558 | 15,797 | 15,757 | 16,316 | 17,015 |
| EBITDA 1 | 3,596 | 3,900 | 4,750 | 5,151 | 4,438 | 5,081 | 5,320 | 5,597 |
| EBIT 1 | 2,927 | 3,069 | 3,812 | 4,468 | 4,620 | 4,364 | 4,587 | 4,824 |
| Net income 1 | 2,255 | 2,194 | 2,642 | 3,002 | -2,579 | 2,822 | 3,149 | 3,348 |
| Net Debt 1 | -778.6 | 10,679 | 10,526 | 8,981 | 9,383 | 9,267 | 8,969 | 8,458 |
| Reference price 2 | 185.38 | 184.61 | 196.96 | 157.01 | 79.38 | 137.43 | 137.43 | 137.43 |
| Nbr of stocks (in thousands) | 481,706 | 482,372 | 483,253 | 484,212 | 478,912 | 478,912 | - | - |
| Announcement Date | 16/08/22 | 14/08/23 | 12/08/24 | 18/08/25 | 17/08/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.35x | 4.71x | 14.6x | 2.21% | 64.9B | |
| 35.75x | 12.79x | 26.94x | 0.55% | 1,106B | |
| 37.14x | 6.26x | 17.62x | 2.1% | 612B | |
| 36.08x | 8.31x | 17.14x | 2.43% | 500B | |
| 20.6x | 4.98x | 12.38x | 2.63% | 367B | |
| 104.7x | 5.86x | 25.15x | 2.37% | 354B | |
| 21.05x | 5.51x | 13.55x | 2.9% | 286B | |
| 21.56x | 4.37x | 12.5x | 2.02% | 256B | |
| 26.98x | 6.96x | 12.46x | 2.37% | 230B | |
| -44.72x | 6.87x | 26.59x | 2.15% | 190B | |
| Average | 28.15x | 6.66x | 17.89x | 2.18% | 396.5B | |
| Weighted average by Cap. | 34.21x | 8.05x | 19.80x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CSL Stock
- Valuation CSL Limited
Select your edition
All financial news and data tailored to specific country editions
